{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:49:59Z","timestamp":1771656599460,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1711,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/ki.2010.520","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T13:49:26Z","timestamp":1300196966000},"page":"697-699","source":"Crossref","is-referenced-by-count":20,"title":["Is ghrelin a biomarker for mortality in end-stage renal disease?"],"prefix":"10.1016","volume":"79","author":[{"given":"Robert H.","family":"Mak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai W.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.520_bb0010","series-title":"2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2003"},{"key":"10.1038\/ki.2010.520_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3945\/ajcn.2008.27390","article-title":"Predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease","volume":"90","author":"Kovesdy","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1038\/ki.2010.520_bb0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2010.487","article-title":"Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients","volume":"79","author":"Carrero","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.520_bb0025","first-page":"567343","article-title":"Ghrelin in chronic kidney disease","volume":"2010","author":"Cheung","year":"2010","journal-title":"Int J Pept [online]"},{"key":"10.1038\/ki.2010.520_bb0030","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1097\/01.ASN.0000032420.12455.74","article-title":"Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Plasma ghrelin and desacyl ghrelin concentrations in renal failure","volume":"13","author":"Yoshimoto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.520_bb0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","article-title":"Ghrelin treatment of chronic kidney disease: improvement in lean body mass and cytokine profile","volume":"149","author":"Deboer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2010.520_bb0040","first-page":"864342","article-title":"Metabolic and cardiovascular effects of ghrelin","volume":"2010","author":"Tesauro","year":"2010","journal-title":"Int J Pept [online]"},{"key":"10.1038\/ki.2010.520_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00395-003-0434-7","article-title":"Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart","volume":"98","author":"Frascarelli","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1038\/ki.2010.520_bb0050","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2010.520_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2009.74","article-title":"Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease","volume":"76","author":"Cheung","year":"2009","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:45:33Z","timestamp":1626867933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815548795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0085253815548795"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.520","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}